Organization · Venture Capital
Prevail Partners LLC
Prevail Partners LLC is a Philadelphia-based venture capital firm specializing in clinical-stage biotech and pharmaceutical companies. The firm focuses on providing capital to promising life sciences companies and facilitating access to emerging medical technologies.
Overview
What Prevail Partners LLC does
What Prevail Partners LLC is
Prevail Partners LLC is a Philadelphia-based venture capital firm specializing in clinical-stage biotech and pharmaceutical companies. The firm focuses on providing capital to promising life sciences companies and facilitating access to emerging medical technologies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2008
- Approximate age
- About 18 years
- Structured capabilities
- Funder
- Last reviewed
- March 31, 2026
Official channels
Find Prevail Partners LLC elsewhere
Open the official website or a supported primary organization account.
Capability profile
Prevail Partners LLC as a funder
Investment thesis
Prevail Partners targets attractive returns from scientific advances in life science fields, bridging capital access to promising clinical-stage companies.
Focus narrative
Prevail Partners invests in clinical-stage companies within the life sciences sector, specifically targeting therapeutics, preventive treatments, medical devices, and diagnostics. The firm is dedicated to supporting innovations that can lead to significant advancements in healthcare.
Value beyond capital
Prevail Partners adds value to its portfolio companies by providing not only capital but also strategic guidance and access to a network of industry experts, helping to navigate the complexities of the life sciences landscape.
Focus and fit
- Stages
- Series A · Series B · Series C · Growth Equity
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 5
- Recorded notable exits
- HemoGenyx and BriaCell Therapeutics
Portfolio context
Prevail Partners has notable portfolio companies including HemoGenyx, a hematology/oncology company that has gone public, and BriaCell Therapeutics, which focuses on immunotherapy for breast cancer. Other active investments include MAIA Biotechnology, Omnix Medical, Nanocan Therapeutics, Triple Hair, and SOM Biotech.
Common questions
What to know about Prevail Partners LLC
Upseed classifies Prevail Partners LLC under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 31, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.